$ARRY Recent News This ‘hideously expensive’ market

New Post Public Reply Private Reply Replies (0) Message Board

Dec 7, 2014 at 11:31 AM

$ARRY Recent News

This ‘hideously expensive’ market has given ‘show horse’ pundits fits 8:58 a.m. Dec. 4, 2014 - Shawn Langlois
PVH shares slip on outlook, Aeropostale’s drop 6:39 p.m. Dec. 3, 2014 - Wallace Witkowski
Friday’s biggest movers; Apple catches a break 4:49 p.m. Nov. 9, 2012 - Sue Chang
Array 18 mln share offering prices at 10% discount 9:19 a.m. Nov. 9, 2012 - MarketWatch.com
Array BioPharma falls 10% in premarket 7:40 a.m. Nov. 9, 2012 - Steve Gelsi
Array BioPharma at $8.5M milestone in Amgen pact 8:30 a.m. July 19, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 3:35 p.m. Feb. 9, 2012 - Kate Gibson
Array Biopharma share sale prices at big discount 9:58 a.m. Feb. 9, 2012 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 5:11 p.m. Jan. 31, 2012 - Kate Gibson
Tuesday's biggest gaining and declining stocks 2:42 p.m. April 20, 2010 - MarketWatch
Human Genome dips; Array rockets 1:31 p.m. April 20, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:19 p.m. Dec. 16, 2009 - MarketWatch
Tuesday's biggest gaining and declining stocks 4:19 p.m. Dec. 15, 2009 - MarketWatch
Friday's biggest gaining and declining stocks 3:51 p.m. Sept. 4, 2009 - MarketWatch
Monday's biggest gaining and declining stocks 3:56 p.m. Sept. 24, 2007 - MarketWatch
Celgene, Array BioPharma in global strategic collaboration 5:38 a.m. Sept. 24, 2007 - Aude Lagorce
Array BioPharma, Celgene announced global R&D collaboration 5:32 a.m. Sept. 24, 2007 - Aude Lagorce
Stocks in focus for Tuesday 5:53 p.m. Aug. 6, 2007 - MarketWatch
Stocks in focus for Wednesday 6:02 p.m. April 10, 2007 - MarketWatch
Array BioPharma: ARRY-797 Phase I trial to begin this year 3:44 p.m. April 10, 2007 - Katherine Hunt

Array BioPharma (ARRY) Shares March Higher, Can It Continue? - Tale of the Tape 9:43 a.m. Dec. 5, 2014 - Zacks.com
Array BioPharma, Inc. (ARRY) in Focus: Stock Soars 14.3% - Tale of the Tape 9:18 a.m. Dec. 5, 2014 - Zacks.com
Array BioPharma Regains Binimetinib Rights from Novartis - Analyst Blog 3:00 p.m. Dec. 4, 2014 - Zacks.com
ARRY Crosses Above Key Moving Average Level 12:21 p.m. Dec. 4, 2014 - TheStreet.com
Mid-Day Market Update: Hawaiian Electric Climbs On Merger News; Barnes & Noble Shares Slide 11:39 a.m. Dec. 4, 2014 - benzinga.com
Why Delta Air Lines, Hawaiian Electric Industries, and Array BioPharma are 3 of Today’s Best Stocks 11:02 a.m. Dec. 4, 2014 - InvestorPlace.com
Array BioPharma: When Losing a Partnership Is Good News 10:03 a.m. Dec. 4, 2014 - 247WallSt.com
Mid-Morning Market Update: Markets Mostly Lower; Dollar General Posts Downbeat Earnings 9:35 a.m. Dec. 4, 2014 - benzinga.com
Array BioPharma (ARRY) Q1 2015 Results - Earnings Call Webcast 8:55 a.m. Dec. 4, 2014 - Seeking Alpha
Morning Market Movers 8:41 a.m. Dec. 4, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:13 a.m. Dec. 4, 2014 - benzinga.com
Array BioPharma to regain global rights to cancer therapy 6:33 p.m. Dec. 3, 2014 - Seeking Alpha
Array Biooharma Regains Rights to Cancer Drug From Novartis 4:01 p.m. Dec. 3, 2014 - TheStreet.com
UPDATE: Array To Regain Worldwide Rights To Binimetinib 3:03 p.m. Dec. 3, 2014 - benzinga.com
Array BioPharma (ARRY) Is Today's Strong On High Volume Stock 10:00 a.m. Nov. 24, 2014 - TheStreet.com
4 Biotech Catalyst Stocks to Buy With 60% to 100% Upside Potential 8:26 a.m. Nov. 20, 2014 - 247WallSt.com
10-Q: ARRAY BIOPHARMA INC 4:20 p.m. Nov. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Array BioPharma's (ARRY) CEO Ron Squarer on Q1 2015 Results - Earnings Call Transcript 11:46 a.m. Nov. 4, 2014 - Seeking Alpha
Array BioPharma (ARRY) Strong On High Relative Volume Today 10:02 a.m. Nov. 4, 2014 - TheStreet.com
Array BioPharma (ARRY) Q1 2015 Results - Earnings Call Webcast 8:55 a.m. Nov. 4, 2014 - Seeking Alpha

Array To Regain Worldwide Rights To Binimetinib 4:01 p.m. Dec. 3, 2014 - PR Newswire - PRF
Array BioPharma To Present At The Piper Jaffray And Oppenheimer 2014 Healthcare Conferences 2:00 p.m. Nov. 25, 2014 - PR Newswire - PRF
Array BioPharma To Present At The Stifel 2014 Healthcare And Jefferies 2014 Global Healthcare Conferences 10:00 a.m. Nov. 10, 2014 - PR Newswire - PRF
Morning Briefing on Biotech Stocks - Arrowhead Research, Array BioPharma, Aegerion Pharma, Hemispherx Biopharma, and Aeterna Zentaris 8:30 a.m. Nov. 5, 2014 - PR Newswire - PRF
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2015 8:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014 12:30 p.m. Oct. 29, 2014 - PR Newswire - PRF
Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical Activity 7:00 a.m. Sept. 29, 2014 - PR Newswire - PRF
Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 7:40 a.m. Sept. 22, 2014 - PR Newswire - PRF
Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer 12:46 p.m. Sept. 12, 2014 - PR Newswire - PRF
Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer 5:12 p.m. Sept. 11, 2014 - PR Newswire - PRF
Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare Conference 3:13 p.m. Sept. 3, 2014 - PR Newswire - PRF
Technical Summary on Biotech Equities -- Alkermes, Amarin, Array BioPharma, Navidea Biopharma, and Pharmacyclics Inc. 8:00 a.m. Aug. 18, 2014 - PR Newswire - PRF
Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 6:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014 10:00 a.m. July 28, 2014 - PR Newswire - PRF
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 5:40 a.m. July 9, 2014 - PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 5:30 a.m. July 3, 2014 - PR Newswire - PRF
Array BioPharma To Present At The Wells Fargo Securities 2014 Healthcare Conference 1:00 p.m. June 11, 2014 - PR Newswire - PRF
Health Care Sector Equities Coverage -- Research on Neurocrine Biosciences, PDL BioPharma, Celgene, and Array BioPharma 6:50 a.m. June 6, 2014 - PR Newswire - PRF
Two Array-Invented MEK Inhibitors Showcased At ASCO 12:00 p.m. June 2, 2014 - PR Newswire - PRF
Array BioPharma Announces Drug Discovery Collaboration Agreement With Biogen Idec 8:00 a.m. May 28, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Common Thread Advisors: Transforming Change in Business

Navigating the Storm of Change: A New Player in Town You know, just when you think you've got the business world figured out, something sharp comes along. Today, it’s Common Thread Advisors, making its grand entrance to help organizations steer through the dense fog of change. This isn’t your everyday, run-of-the-mill consultancy. No sir, they’re out here with a...

Everon Tops Industry: Integrator of the Year Win

Everon Claims the Coveted 2026 Integrator of the Year Award There's a new heavyweight in town, folks. Everon has snagged the Integrator of the Year award for 2026, and they're not just resting on their laurels about it. Named by industry titans NSCA, Commercial Integrator, and Security Sales & Integration, this accolade isn't just a flashy tick box—it’s a testament to...

Icahn Enterprises Set for Q3 Earnings Review

Icahn Enterprises Prepares for Third Quarter Insights There's something about quarterly earnings calls that gets the adrenaline pumping for investors, especially when it's about a giant like Icahn Enterprises L.P. We're talking a behemoth that wrestles in everything from energy to food packaging. If you're not eyeing this already, you probably should be. On November 3,...

Hallmark's Holiday Magic: Cards, Ornaments, Joy

Hallmark's Seasonal Bonanza: Cards, Gifts, and More It's that time again when Hallmark rolls out the holiday carpet, the red one you usually just see in front of fancy theaters. Greeting cards, gifts, Keepsake Ornaments, and those nostalgic holiday flicks on Hallmark Channel—it's a full-on festive fiesta. But it's not just about shoving a card in an envelope; it's about...

MidCap Financial Faces Scrutiny Amid Ares Capital Merger

MidCap Financial's Merger Sparks Legal Action Nobody expects their investments to end up in a courtroom drama, but here we are. MidCap Financial Investment Corporation (NASDAQ: MFIC) is under the microscope, thanks to attorney Juan Monteverde's M&A Class Action Firm. From their perch in the Empire State Building, Monteverde & Associates, celebrated as a top dog in the ISS...

Chedraui's Q3 '26 Balancing Act: Highlights and Hurdles

Mexico's Retail Giant Battles Mixed Outcomes Wading through the latest quarterly scrimmage, Grupo Comercial Chedraui reports that the game plan hasn't changed—stick to low prices, varied assortments, and cracking customer experiences. But the scoreboard's got a few odd numbers, and depending on where you sit, the tally looks slightly uneven. Same Store Sales: A Regional...

CapCut Leads 2026 AI Image Tools for Creatives

CapCut Emerges as a Go-To in AI Imagery There's no better feeling than striking gold in a flooded market. CapCut's got folks buzzing in 2026 for its top-tier AI image creation tools, according to Expert Consumers' latest rankings. On the surface, it might just seem like another tech gimmick, but dig a bit deeper, and you'll see why it's a game changer. From adland to...

Duolingo Faces Securities Fraud Lawsuit: Key Deadline Looms

Duolingo Finds Itself in Deep Waters Did you ever think the darling of language apps, Duolingo, would be staring down the barrel of a securities fraud lawsuit? Well, here we are. The company's tangled up in a legal web over alleged shifty business practices, and investors who bought Duolingo Class A stock between May 2, 2025, and February 26, 2026, are at the center of...

Yuchai Eyes African Market Expansion with Strategic Visits

Yuchai's Bold Move into Africa There's something gutsy about a company that doesn't just sit on its achievements but heads out into new territories. China Yuchai International (NYSE: CYD), a big player in powertrain solutions, recently embarked on a strategic tour across the African continent, a move that could well shape their future market playbook. East Africa:...

Lectric eBikes Unveils XP Lite3 with Major Upgrades

Packing Features Without the Price Hike Alright folks, Lectric eBikes just dropped the XP Lite3 onto the scene and, believe me, the air's buzzing. You know how they say the third time's a charm? Well, it sure as heck applies here. Instead of jacking up the price, they're holding on to that $799 sticker like a stubborn mule in a rising-tide economy. And let's chew on that...